Proteome Sciences plc (AIM:PRM)
London · Delayed Price · Currency is GBP · Price in GBX 1.990
+0.185 (10.25%)
Aug 17, 2026, 9:09 AM GMT
Proteome Sciences Market Cap
Proteome Sciences has a market cap or net worth of 6.33 million as of August 14, 2026. Its market cap has decreased by -28.51% in one year.
Market Cap
6.33M
Enterprise Value
21.32M
Revenue
3.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.99
ChartMarket Cap Chart
Since March 1, 1999, Proteome Sciences's market cap has decreased from 11.17M to 6.33M, a decrease of -43.33%. That is a compound annual growth rate of -2.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 6.33M | -14.21% |
| Dec 31, 2025 | 7.38M | -26.47% |
| Dec 31, 2024 | 10.04M | -24.94% |
| Dec 29, 2023 | 13.37M | 29.43% |
| Dec 30, 2022 | 10.33M | -31.71% |
| Dec 31, 2021 | 15.13M | 32.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.75B |
| GSK plc | 72.83B |
| Haleon | 31.32B |
| Smith & Nephew | 9.22B |
| Cizzle Biotechnology Holdings | 7.01M |
| GENinCode | 6.66M |
| OptiBiotix Health | 5.94M |
| CRISM Therapeutics | 5.83M |